0
0
0
To amend the Federal Food, Drug, and Cosmetic Act to restrict direct-to-consumer drug advertising.
7/26/2024, 8:06 AM
Current Status of Bill HR 9142
Bill HR 9142 is currently in the status of Bill Introduced since July 25, 2024. Bill HR 9142 was introduced during Congress 118 and was introduced to the House on July 25, 2024. Bill HR 9142's most recent activity was Referred to the House Committee on Energy and Commerce. as of July 25, 2024
Bipartisan Support of Bill HR 9142
Total Number of Sponsors
1Democrat Sponsors
1Republican Sponsors
0Unaffiliated Sponsors
0Total Number of Cosponsors
0Democrat Cosponsors
0Republican Cosponsors
0Unaffiliated Cosponsors
0Policy Area and Potential Impact of Bill HR 9142
Primary Policy Focus
Alternate Title(s) of Bill HR 9142
To amend the Federal Food, Drug, and Cosmetic Act to restrict direct-to-consumer drug advertising.
To amend the Federal Food, Drug, and Cosmetic Act to restrict direct-to-consumer drug advertising.
Comments
Sponsors and Cosponsors of HR 9142
Latest Bills
Honduras Expropriation Accountability Act
Bill HR 7807March 24, 2026
Debt-to-GDP Transparency and Stabilization Act
Bill HR 7808March 24, 2026
Responsible Containment Reauthorization Act
Bill HR 7811March 24, 2026
BLS Act
Bill HR 7804March 24, 2026
Direct File Act of 2026
Bill HR 7806March 24, 2026
Red Star Service Banner Act
Bill HR 7815March 24, 2026
Lowering Student Loans Act
Bill HR 7810March 24, 2026
HEALTHY BRAINS Act of 2026
Bill HR 7779March 24, 2026
Parity for Tribal Educators Act
Bill HR 7781March 24, 2026
A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by Bureau of Consumer Financial Protection relating to the withdrawal of the rule relating to "Debt Collection Practices (Regulation F); Deceptive and Unfair Collection of Medical Debt".
Bill SJRES 141March 24, 2026